Showing results (71-80 of 275) with videos related to

Sort By:
Pageof 28
The Korean Journal of Laboratory Medicine|July 3, 2009
[Usefulness of real-time semi-quantitative PCR, JAK2 MutaScreen kit for JAK2 V617F screening]Hyojin Chae, Je Hoon Lee, Jihyang Lim, et al.
International Journal of Molecular Sciences|October 16, 2024
SARS-CoV-2-Specific T-Cell as a Potent Therapeutic Strategy against Immune Evasion of Emerging COVID-19 VariantsKeon-Il Im, Nayoun Kim, Junseok Lee, et al.
Diagnostics (Basel, Switzerland)|September 9, 2023
Prognostic Value of FDG PET/CT in Patients with Nodal Peripheral T-Cell LymphomaWoo Hee Choi, Eun Ji Han, Joo Hyun O, et al.
Yonsei Medical Journal|June 27, 2008
Vascular endothelial growth factor levels in ascites between chemonaive and chemotreated patientsHae Kyung Lee, Hiun Suk Chae, Jin Soo Kim, et al.
Plos One|August 14, 2013
The synergistic immunoregulatory effects of culture-expanded mesenchymal stromal cells and CD4(+)25(+)Foxp3+ regulatory T cells on skin allograft rejectionJung Ho Lee, Eun-Joo Jeon, Nayoun Kim, et al.
Plos One|May 30, 2015
Measurement of CD8+ and CD4+ T Cell Frequencies Specific for EBV LMP1 and LMP2a Using mRNA-Transfected DCsDae-Hee Sohn, Hyun-Jung Sohn, Hyun-Joo Lee, et al.
International Journal of Hematology|December 1, 2017
Infusions of Epstein-Barr virus-specific cytotoxic T lymphocytes as post-remission therapy in high-risk post-transplant lymphoproliferative disorder patients: report of two casesNayoun Kim, Hyun-Jung Sohn, Joo Hyun Oh, et al.
Annals of Hematology|November 20, 2010
Pilot study of pegylated interferon alpha-2a treatment during chemo- and radiotherapy and post-remission maintenance in patients with EBV-positive extranodal NK/T cell lymphomaSung-Yong Kim, Seok-Goo Cho, Sung-Won Kim, et al.
EJNMMI Research|November 23, 2019
Role of F-18 FDG PET/CT in non-conjunctival origin ocular adnexal mucosa-associated lymphoid tissue (MALT) lymphomasHye Lim Park, Joo Hyun O, Sonya Youngju Park, et al.
Plos One|July 11, 2013
Curcumin attenuates acute graft-versus-host disease severity via in vivo regulations on Th1, Th17 and regulatory T cellsMin-Jung Park, Su-Jin Moon, Sung-Hee Lee, et al.
Pageof 28